Published in Mol Psychiatry on August 30, 2011
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Do initial responses to drugs predict future use or abuse? Neurosci Biobehav Rev (2012) 1.26
GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data. Genome Biol (2013) 1.11
Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry (2014) 1.01
A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor. Sleep (2012) 0.94
Genetic comorbidities in Parkinson's disease. Hum Mol Genet (2013) 0.89
Caffeine Use Disorder: A Comprehensive Review and Research Agenda. J Caffeine Res (2013) 0.89
Systems Epidemiology: A New Direction in Nutrition and Metabolic Disease Research. Curr Nutr Rep (2013) 0.87
Rare coding variants and X-linked loci associated with age at menarche. Nat Commun (2015) 0.87
Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease. PLoS Genet (2014) 0.86
Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. Int J Epidemiol (2015) 0.86
Bioinformatic Resources of microRNA Sequences, Gene Targets, and Genetic Variation. Front Genet (2012) 0.84
Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption. PLoS One (2014) 0.82
Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. Diabetes Technol Ther (2015) 0.81
Association analysis of bitter receptor genes in five isolated populations identifies a significant correlation between TAS2R43 variants and coffee liking. PLoS One (2014) 0.77
Expression of arachidonic acid-metabolizing cytochrome P450s in human megakaryocytic Dami cells. In Vitro Cell Dev Biol Anim (2013) 0.76
Non-additive genome-wide association scan reveals a new gene associated with habitual coffee consumption. Sci Rep (2016) 0.76
Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects. Twin Res Hum Genet (2012) 0.76
Coffee, Genetic Variants, and Parkinson's Disease: Gene-Environment Interactions. J Caffeine Res (2015) 0.75
Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study. Sci Rep (2016) 0.75
A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma. Carcinogenesis (2016) 0.75
Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. Int J Cancer (2016) 0.75
Coffee consumption is associated with DNA methylation levels of human blood. Eur J Hum Genet (2017) 0.75
Does coffee consumption impact on heaviness of smoking? Addiction (2017) 0.75
The Taste of Caffeine. J Caffeine Res (2017) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet (2007) 52.68
A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet (2009) 30.09
Population genomics of human gene expression. Nat Genet (2007) 24.49
Genotype imputation. Annu Rev Genomics Hum Genet (2009) 18.64
GenABEL: an R library for genome-wide association analysis. Bioinformatics (2007) 18.10
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Transcriptome genetics using second generation sequencing in a Caucasian population. Nature (2010) 14.85
A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Family-based association tests for genomewide association scans. Am J Hum Genet (2007) 10.67
PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res (2009) 9.14
KORA-gen--resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen (2005) 7.93
ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics (2010) 6.46
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 6.26
Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res (2001) 4.50
Cohort profile: the study of health in Pomerania. Int J Epidemiol (2010) 4.38
Coffee and cancer of the pancreas. N Engl J Med (1981) 3.79
The UK Adult Twin Registry (TwinsUK). Twin Res Hum Genet (2006) 3.72
Netherlands Twin Register: from twins to twin families. Twin Res Hum Genet (2006) 3.71
A genomic background based method for association analysis in related individuals. PLoS One (2007) 3.46
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med (2006) 3.33
Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2006) 3.19
Common variants in the trichohyalin gene are associated with straight hair in Europeans. Am J Hum Genet (2009) 3.18
Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed (2001) 3.17
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09
Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr (2006) 2.72
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol (1999) 2.57
Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA (2006) 2.40
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A (1989) 2.25
Coffee, tea, and mortality. Ann Epidemiol (1993) 2.17
Does caffeine enhance or merely restore degraded psychomotor performance? Neuropsychobiology (1994) 2.10
Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA (2004) 2.03
A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) (2004) 1.81
Linkage disequilibrium in young genetically isolated Dutch population. Eur J Hum Genet (2004) 1.80
Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet (2011) 1.77
Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology (2010) 1.75
Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells. Oncogene (2006) 1.57
How does parkin ligate ubiquitin to Parkinson's disease? EMBO Rep (2004) 1.54
The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther (1993) 1.51
Counteracting driver sleepiness: effects of napping, caffeine, and placebo. Psychophysiology (1996) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr (2010) 1.38
Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr (1999) 1.36
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr (2007) 1.32
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics (1992) 1.31
Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Hum Genet (2007) 1.25
NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology (2006) 1.24
Mutagens in coffee and tea. Mutat Res (1979) 1.17
Coffee and tea consumption and risk of type 2 diabetes. Diabetologia (2009) 1.17
Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences. J Subst Abuse (1990) 1.15
The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. J Subst Abuse (1996) 1.14
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics (2002) 1.14
Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics (2001) 1.11
Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend (1998) 1.11
Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology (2004) 1.08
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry (1998) 1.07
Effects of caffeine in non-withdrawn volunteers. Hum Psychopharmacol (2005) 1.06
The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension (1999) 1.05
Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet (2011) 1.03
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens (2009) 0.99
The genetics of tea and coffee drinking and preference for source of caffeine in a large community sample of Australian twins. Addiction (2005) 0.98
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev (2007) 0.98
Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study. Nutr Cancer (2007) 0.97
Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol (1998) 0.95
Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr (2010) 0.94
Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Public Health Nutr (2010) 0.93
Coffee and ovarian cancer. Int J Cancer (1981) 0.93
The effects of coffee consumption on sleep and melatonin secretion. Sleep Med (2002) 0.92
Neuronal cell adhesion molecule deletion induces a cognitive and behavioral phenotype reflective of impulsivity. Genes Brain Behav (2007) 0.92
Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health (1993) 0.91
A genetic analysis of coffee consumption in a sample of Dutch twins. Twin Res Hum Genet (2009) 0.89
Genetics of coffee consumption and its stability. Addiction (2008) 0.89
Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling. Physiol Genomics (2009) 0.88
Hypocretins: the timing of sleep and waking. Chronobiol Int (2006) 0.88
Caffeine as a model drug of abuse. Trends Pharmacol Sci (1990) 0.88
CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico. Toxicol Lett (2005) 0.87
Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1998) 0.87
Association analysis of the NrCAM gene in autism and in subsets of families with severe obsessive-compulsive or self-stimulatory behaviors. Psychiatr Genet (2006) 0.86
Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review. Mutat Res (1994) 0.85
Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology (Berl) (1994) 0.85
A comparison of early and late respondents in a twin-family survey study. Twin Res Hum Genet (2008) 0.84
Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol Appl Pharmacol (1998) 0.82
Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behav Pharmacol (1991) 0.81
Urinary biomarkers for assessing dietary exposure to caffeine. Food Addit Contam (2001) 0.81
NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. Br J Cancer (2007) 0.79
Contribution of coffee aroma constituents to the mutagenicity of coffee. Food Chem Toxicol (1989) 0.78
N-2 acetylation of 2'-deoxyguanosine by coffee mutagens, methylglyoxal and hydrogen peroxide. Mutat Res (1990) 0.78
Identification of cytochrome P450 1A1 in human brain. Biochem Biophys Res Commun (1998) 0.78
Effects of caffeine, time of day and user history on study-related performance. Psychopharmacology (Berl) (1992) 0.77
Inhibition of iron absorption by coffee and the reduced risk of type 2 diabetes mellitus. Arch Intern Med (2007) 0.77
[Caffeine as a preventive drug for Parkinson's disease: epidemiologic evidence and experimental support]. Rev Neurol (2010) 0.77
Caffeine dependence: fact or fiction? J R Soc Med (1995) 0.76
Caffeine use: is there a net benefit for mood and psychomotor performance? Neuropsychobiology (1995) 0.76
Caffeine and psychomotor performance revisited. Neuropsychobiology (1995) 0.76
The sequence of the human genome. Science (2001) 101.55
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol (1993) 51.00
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol (1997) 15.19
Allegro, a new computer program for multipoint linkage analysis. Nat Genet (2000) 14.00
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Obesity, cigarette smoking, and telomere length in women. Lancet (2005) 8.59
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
New goals for the U.S. Human Genome Project: 1998-2003. Science (1998) 8.30
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
The genetics of haemostasis: a twin study. Lancet (2001) 8.08
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet (1984) 7.97
DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell (1991) 7.93
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell (1996) 7.86
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
A DNA polymorphism discovery resource for research on human genetic variation. Genome Res (1998) 7.44
A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet (1994) 7.04
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum (2000) 6.88
The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell (2006) 6.80
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest (1971) 6.09
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Smoking, smoking cessation, and major depression. JAMA (1990) 5.89
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature (2000) 5.71
Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med (1997) 5.69
Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Communication failures in patient sign-out and suggestions for improvement: a critical incident analysis. Qual Saf Health Care (2005) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res (1999) 5.35
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Social epidemiology? No way. Int J Epidemiol (2001) 5.25
High-throughput variation detection and genotyping using microarrays. Genome Res (2001) 5.24
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J (1998) 5.21
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol (2000) 5.20
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89
Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet (2000) 4.74
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64
Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (1992) 4.53
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res (2001) 4.50
Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J Cell Biol (1978) 4.50
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44